Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Inflammation causes heart disease. Read the book titled: The Great Cholesterol Myth by Stephen Sinatra (Author), Jonny Bowden
Available as a paperback, kindle ebook, or audio CD from Amazon
Excerpt:
"Inflammation is the true cause of heart disease. (Chapter 3)---Chronic inflammation kills. Much like blood pressure, it has no obvious symptoms until too late.
'Chronic inflammation' is a signficant component of virtually every single degenerative condition including Alzheimer's, diabetes, obesity, arthritis, cancer, neurodegenerative diseases, chronic lower respiratory disease, influenza and pneumonia, chronic liver and kidney disease, and most especially, heart disease."
Though the main thesis of this book is the misuse of statin drugs, it tries to explain the myth of cholesterol connection to cardiovascular problems. In this discussion the process and causes of cardiovascular issues is explained.
Amazon link at:
http://www.amazon.com/Great-Cholesterol-Myth-Disease--Statin-Free-ebook/dp/B009PKIPOE/ref=sr_1_1?s=digital-text&ie=UTF8&qid=1383721468&sr=1-1&keywords=myth+statins
Abstract from NCBI says TgAb is the main marker of Hashimoto's Thyroiditis.
The mechanism of disease progression in Hashimoto's thyroiditis (HT) is still unclear. Thyroglobulin antibody (TgAb) is a diagnostic hallmark of HT. The aim of our study was to evaluate the avidity of TgAb in sera from HT patients with different thyroid functional status. Sera from 50 patients with newly diagnosed HT were collected and divided into three groups according to thyroid function: patients with hypothyroidism (H, n = 18), subclinical hypothyroidism (sH, n = 18) and euthyroidism (Eu, n = 14). Titres and avidity of TgAb were determined by enzyme-linked immunosorbent assays (ELISAs). Avidity constant (aK) was determined as the reciprocal value of the thyroglobulin molar concentration in the liquid phase resulting in 50% inhibition of TgAb binding to thyroglobulin in solid-phase ELISAs. The titres and aK of TgAb were performed using log-transformation, and expressed as lgT and lgaK, respectively. Mean lgT of TgAb in sera was 4·19 ± 0·60 in H, 3·77 ± 0·63 in sH, and 3·29 ± 0·64 in Eu, respectively. The median avidity of TgAb was 2·30 × 109 in H, 8·80 × 108 in sH, 2·00 × 107 in Eu, respectively. lgT and lgaK of TgAb were at significantly lower levels in Eu than in sH and H (P < 0·05). Correlation was found between lgT and lgaK (r = 0·594, P < 0·05). lgaK was also related to TSH (r = 0·308, P < 0·05). Our study indicated that patients with high-avidity TgAb might be at high risk of developing subclinical, even to overt, hypothyroidism.
Article at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940150/
Word is spreading, see link at Godlike Productions:
http://www.godlikeproductions.com/forum1/message2104224/pg1
They used the 'sweetened' version of Anatabloc. I wonder what the AE would have been without.
Yikes! Everyone is investigating INFLAMMATION. Take a gander at the outline for this expensive report of who's who and what's what and where regarding research into inflammation:
Inflammation Global Clinical Trials Review, H2, 2013
Article at: http://www.digitaljournal.com/pr/1550101
"Cancer the Forbidden Cures"---Video well worth the watch, little over an hour. Is this Anatabloc's fate or does Anatabloc become the nutraceutical that succeeds because it is patented? Fascinating history of those who fought the FDA, AMA, and Big Pharma. What do you think?
Prescription Drugs Kill Over 100,000 People Each Year, Are You Being Medicated Incorrectly?
Excerpt from article:
"Prescription drugs are currently responsible for more deaths annually than illegal drugs. According to Tom Frieden, the CDC director himself, “it’s a big problem, and it’s getting worse [3].”
"Out of the 783,936 annual deaths from conventional medicine mistakes, approximately 106,000 of those are the result of prescription drug use [1]. According to the Journal of the American Medical Association, two-hundred and ninety people in the United States are killed by prescription drugs every day [4].
Even if prescription drugs do not literally kill a patient though, they slowly kill their mind and body. This alters their ability to innately feel deeply and compassionately, the patient can be stripped piece by piece of his inner awareness and inner consciousness, the very essence of their being."
- See more at: http://www.collective-evolution.com/2013/05/07/death-by-prescription-drugs-is-a-growing-problem/#_
"Side effects of Common Arthritis Drugs" video at:
"An Overview of Global Regulatory Trends in the Nutraceutical Industry – April 2013"
Excerpt from article:
"* Generally the goals of nutraceutical regulation have been focused on safety and labeling with lesser emphasis (as compared to pharmaceuticals) on product claims and intended use. This is achieved through Good Manufacturing Practice (GMP) regulations and a recent increase in enforcement.
* Consumers are largely responsible for determining the usefulness and value offered by nutraceutical products, although regulatory agencies are increasingly enforcing industry requirements that call for nutraceutical companies to track adverse events.
* There is consensus among nutraceutical companies that increased regulation related to quality and safety will benefit the industry, and help mitigate the risk of regulatory backlash if scrupulous players engage in abusive practices and are left unchecked.
* Greater enforcement of GMP regulations are likely to drive further consolidation in the relatively young, fragmented industry as those lacking proper scale are unable to comply with the greater emphasis on regulation or make the necessary investments to become compliant across multiple jurisdictions."
"The Nutraceutical Market
Bourne Partners released an April 2013 Nutraceutical Sector Report (free download) that put the global nutraceutical market at $142 billion in 2011. With an estimated growth rate of 6.4% (CAGR), the market is expected to reach $204.8 billion by 2017. Growth is being driven by favorable demographics, increases in disposable income, rising healthcare costs and an increasingly robust OTC market. In developing nations, the middle classes are growing, which translates to increased disposable income because of typically regressive tax structures. Also, developing nations are increasingly becoming the preferred source for cheaper raw material supply found in many nutraceutical products."
Article at:
http://bournepartners.wordpress.com/2013/04/22/an-overview-of-global-regulatory-trends-in-the-nutraceutical-industry-april-2013/
"A nutraceutical a day may keep the doctor away"
. Article in U.S. National Library of Medicine.
Excerpt from the article:
"“The consumption of food supplements in the USA, Europe and Japan is roughly a US$170 billion industry,” according to Peter Baskauskas, national sales manager of Quality of Life Labs (Purchase, NY, USA). “The US accounts for about US$75 billion of that.” This figure is higher than that cited by the National Nutritional Foods Association (NNFA; Newport Beach, CA, USA), which stated that functional food and supplement sales were US$41.7 billion in 2003. Regardless of the exact figures, market reports observe that the interest in nutraceuticals is growing rapidly worldwide. In the USA alone, about 6 out of 10 consumers take some type of food supplement, and 30%–40% take herbal supplements. Whereas about a decade ago, most people took either drugs or supplements, there is now an increasing crossover between the factions, and even some physicians are recommending natural products before prescribing pharmaceuticals. Driving this boom is consumer disappointment with Western medicine and a strong interest in improving health and well-being. “The trend also reflects the growth of a new paradigm of 'self-care',” according to Fergus Clydesdale, head of the Department of Food Science at the University of Massachusetts (Amherst, MA, USA).
Driving this boom is consumer disappointment with Western medicine and a strong interest in improving health and well-being
A 2001 poll by Harris Interactive (Rochester, NY, USA) revealed that 72% of those surveyed in the USA take supplements to feel better, 67% to prevent illness, 50% to live longer, 37% to build muscle and strength, 12% for weight management and 33% on the advice of a physician. Significantly, 53% said that nutraceuticals offer benefits not matched by conventional drugs, and 56% said they offered benefits comparable with drugs but with fewer side effects. Remarkably, 95% were satisfied with supplements "
Article at:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1369156/
Another interesting SA article, this on aging:
Ask the Experts: Can Aging Be Controlled?
Excerpt from the article:
"One of the protective mechanisms that we have evolved against cancer is called cell senescence. When a cell is damaged it either dies in a process called apoptosis or it simply stops dividing. That's cell senescence.
A few years ago, we learned that when cells opt to senesce they don't die. They persist. They increase with age. And they secrete inflammatory cytokines. So they can produce low level of chronic inflammation throughout the body with no obvious pathogen, and we think that is one of the drivers of aging. This is an example of an evolutionary trade-off. If you don't have the senescence mechanism, you die early of cancer. But if you do have this mechanism, you die later and miserably.
Do I think if I had a drug tomorrow that could kill senescent cells, it would make a human live for 5,000 years? No, I don't. But it might help attack several problems of aging—like Parkinson's disease or Alzheimer's disease—that involve a lot of inflammation. The idea would be not to treat one disease at a time, but to get at the underlying processes, like inflammation."
Article at:
http://www.scientificamerican.com/article.cfm?id=aging-ask-the-experts-can-aging-be-controlled&page=2
More food for thought: Scientific American article: Is Chronic Inflammation the Key to Unlocking the Mysteries of Cancer?
Quote from the article: "In 2004 Yinon Ben-Neriah and Eli Pikarsky of the Hebrew University of Jerusalem and their colleagues reported that mice engineered to develop hepatitis (which can cause liver cancer) contracted precancerous lesions that did not progress to full malignancy when NF-KB was curtailed through a genetic alteration or when the proinflammatory TNF signaling molecule was shut off. In the latter group, a neutralizing antibody blocked TNF and prevented it from binding to a receptor on the premalignant liver cells; loss of the receptor prevented the TNF from triggering a molecular cascade that turns on the NF-KB master switch. Blocking NF-KB prompted the precancerous liver cells to initiate apoptosis, or programmed cell death. In a related finding that year, Michael Karin and his collaborators at the University of California, San Diego, found that inhibiting NF-KB in mice engineered to develop colitis, which can lead to colon cancer, also promoted apoptosis. And shutting down the pathway in inflammatory cells, such as macrophages, deterred tumor development as well."
Article at: http://www.scientificamerican.com/article.cfm?id=chronic-inflammation-cancer&page=3
Burton J. Haynes, Esq. From the STSI website:
"Burton J. Haynes has served as a member of our Board of Directors since October 22, 2010. Since 1997, Mr. Haynes has served as the sole principal in Burton J. Haynes PC, a law firm specializing in income tax matters, estate and tax planning and complex civil and criminal tax cases. Between 1988 and 1996, Mr. Haynes practiced law as a named partner in the law firm of Bodzin, Haynes & Golub, specializing in civil and criminal tax cases. Mr. Haynes was a partner at the law firm of Finley, Kumble, Wagner, Heine, Underberg, Manley, Myerson & Casey from 1981 to 1988. Prior to entering private practice, Mr. Haynes served as a Special Agent, IRS Criminal Investigation Division from 1973 to 1981. As a Special Agent, Mr. Haynes worked closely with the FBI and U.S. Attorney’s Office on criminal investigations and was named criminal investigator of the year in 1980 by the Association of Federal Investigators. Mr. Haynes received his Bachelor of Arts Degree in Business Administration from the University of Maryland in 1972 and received a Masters Degree in Business Administration from the University of Maryland Graduate School in 1975. He received his law degree in 1979 from the University of Maryland, where he was the recipient of the W. Calvin Chestnut award and the John L. Thomas prize for outstanding scholarship and was elected Order of the Coif. Mr. Haynes is a member of the bars of the District of Columbia, Maryland and Virginia and is a Certified Public Accountant (although his CPA license is in inactive status because his primary focus is on the practice of law). He served as an adjunct professor from 1979 to 1981 at Towson State University in Maryland, where he taught courses in accounting and tax law.
Mr. Haynes was nominated to serve on our Board of Directors based on his extensive experience in business, legal and complex tax, litigation and regulatory matters. His background as an accountant and attorney provides a unique combination of disciplines as does his long career in dealing with complex civil and criminal tax matters. Our Board of Directors viewed Mr. Haynes’ combination of training and experience as a valuable source of expertise, particularly in the areas of financial analysis and planning. Mr. Haynes’ expertise is also valuable in dealing with the type of regulatory issues facing our company as a tobacco manufacturer and in connection with our ongoing efforts relating to the development and marketing of pharmaceutical and nutraceutical products."
Say it again! INFLAMMATION is the enemy.
Forget Cholesterol, Inflammation's the Real Enemy - CBN.com is a You Tube video that is non-technical and easy to understand. It runs about 14 minutes. Forget Lipitor, Anatabloc is your friend.
See at:
OK, thanks! I tried to follow instructions and apparently got lost.
But this is for 2012?
"NF-kappaB inhibition combined with HO-1 inhibition potentially provides a novel therapeutic approach to treat chemotherapy-resistant forms of AML."
Article at: http://www.ncbi.nlm.nih.gov/pubmed/20332229
Another 'no facts' hit piece from 'Investor Place': Trade of the Day: Star Scientific (STSI)
Political scandal, shoddy science and deteriorating technicals all point to a short trade
Article at: http://investorplace.com/2013/10/trade-day-star-scientific-stsi/
With all the 'cliff hanging' drama in Washington, the thing that got this started was Obamacare. The Republican side thinks Obamacare will bankrupt the United States, more specifically the Tea Party advocates. We are getting sicker not healthier. What seems to be missing in all this is how to get us healthier and also reduce medical cost/care so healthcare becomes affordable. Also missing is how we can change our dietary and health habits so we aren't so prone to serious illness/diseases. It is looking like many of these problems are caused by chronic inflammation. The major drivers should be focused on preventive care and solutions so overall (expensive) medical costs can be reduced. I submit to you that Anatabloc, after the research verifies efficacy, could be a key link used by itself or in combination with other medication. It has the potential to beome the backbone of modern medicines and healthy life style. The analogy mentioned before was aspirin and penicillin. When Anatabine Citrates full potential is realized, we will wonder how we did without it. Just maybe Anatabloc is the Phoenix of mankind.
Let's see what the coming quarter says. Only recently has Lucky Vitamin started to sell Anatabloc. They have free shipping for orders over $49, approx $15 credit after first purchase (per bottle), no tax if you don't live in NJ, and regular price is $80/bottle. I've been told that lucky was bought by GNC. So, it would appear Anatabloc is being sold at Rock Creek (and Amazon), GNC, and Lucky. I got to believe it is ramping up but last quarter the increase hidden by new GAAP 'cost of sales' rule.
New hit piece: Star Scientific: Cash Strapped And Under The Influence Of Death-Spiral Financing--Seeking Alpha by Paulo Santos. Article at: http://seekingalpha.com/article/1744142-star-scientific-cash-strapped-and-under-the-influence-of-death-spiral-financing?source=email_rt_article_readmore
Dr Bernstein video on the chronic inflammation connection. Another good short video explaining the connection between chronic inflammation and diseases. Is Anatabloc the missing link?
Is Your Body Burning Up with Hidden Inflammation? Simple to understand video about inflammation and connection to diseases. This video made in 2009 before Anatabloc was available. Sounds like even doctors are unaware of the connection. Video on YouTube at:
Nobel Prize winners---Isn't this what NF-kB is all about?
http://www.bbc.co.uk/news/health-24427951
Suppression of NF-kB aids Cancer treatment. Article at: http://books.google.com/books?id=0slZgloI9SUC&pg=PA227&lpg=PA227&dq=cml+inflammation&source=bl&ots=zgfWuMAikY&sig=_yv07cHujXJQlm5-QvOahNZIAL4&hl=en&sa=X&ei=7yVQUoCzKYzyigLJjIDgCw&ved=0CKUBEOgBMAk#v=onepage&q=cml%20inflammation&f=false
From the book: "The Link Between Inflammation and Cancer: Wounds that do not heal"
edited by Angus G. Dalgleish, Burkhard Haefner
Johnny Williams are you watching? Interesting story in "WIRED" magazine about Tagatose, reads like Johnny and Anatabloc. Article at:
http://www.wired.com/wired/archive/11.11/newsugar_pr.html
Enjoy!
"if we get all tobacco smokers to switch from regular cigarettes to electronic cigarettes, we would eventually reduce the US death toll from more than 400,000 a year to less than 4,000, maybe as low as 400."
Article at: http://www.dailyconsumeralert.net/home/
What role might Anatabloc play in minimizing TBI in sports?
http://www.cnn.com/video/data/2.0/video/bestoftv/2013/09/18/high-school-football-player-dies-gupta-newday.cnn.html
"The Role of Chronic Inflammation in Obesity-Associated Cancers" is a more technical and detailed article conveying the same message of chronic inflammation linked to cancer. From the ISRN Oncology Journal.
Excerpt:
"There is a strong relationship between metabolism and immunity, which can become deleterious under conditions of metabolic stress. Obesity, considered a chronic inflammatory disease, is one example of this link. Chronic inflammation is increasingly being recognized as an etiology in several cancers, particularly those of epithelial origin, and therefore a potential link between obesity and cancer. In this review, the connection between the different factors that can lead to the chronic inflammatory state in the obese individual, as well as their effect in tumorigenesis, is addressed. Furthermore, the association between obesity, inflammation, and esophageal, liver, colon, postmenopausal breast, and endometrial cancers is discussed."
Article at: http://www.hindawi.com/isrn/oncology/2013/697521/
Inflammation Cancer Link
Article from Cancer Research UK:
"Feeling the heat – the link between inflammation and cancer"
Excerpt:
"The heat is on!
While we might not be able to live without it, too much inflammation can cause serious damage. Chronic, persistent inflammation is behind a host of health problems such as rheumatoid arthritis and psoriasis. And after finding immune cells in tumour samples, Rudolf Virchow was the first to ask whether inflammation might also contribute to cancer.
Unfortunately, he was right – many chronic inflammatory diseases (such as pancreatitis and Crohn’s disease) can increase a person’s cancer risk. And cancers caused by infectious agents (like stomach cancer caused by infection with the bacteria Helicobacter pylori, or liver cancer caused by infection with the hepatitis B or C virus) are characterised by one thing: chronic inflammation.
In the case against inflammation, the evidence is damning.
Rudolf Virchow was the first to link inflammation and cancer
It’s getting hot in here
So how does inflammation lead to cancer? Here’s the current thinking.
When a tiny tumour starts growing from a few rogue cells, it can scavenge enough oxygen and nutrients from its surroundings. But as it grows bigger, demand starts to outstrip supply, and things start getting desperate.
As they struggle to survive, and as they accumulate more and more genetic faults, the cancer cells release chemical signals that lure immune cells called macrophages and granulocytes to infiltrate the tumour.
Once inside the tumour’s inner sanctum, these cells secrete molecules (called cytokines) that kick-start the growth of blood vessels (angiogenesis), which ferry in much-needed oxygen and nutrients.
Other cytokines encourage growth of a sort of cellular ‘pillow’ called the stroma against which the tumour rests. Meanwhile, other inflammatory cells spritz the tumour with molecules (free radicals) that further damage their DNA. Inflammation might also fire the starting gun for metastasis by producing chemicals that help tumour cells nibble through the molecules tethering them to their surroundings.
Taken together, it’s clear that fledgling tumours hijack inflammation and use it to accelerate the progression towards full-blown cancer. As one of our own experts once commented:
“If genetic damage is the match that lights the fire, inflammation may provide the fuel that feeds the flames.”
Stay cool, boy
So how do we turn down the heat? Scientists, including our own are working on how to dampen inflammation, making it much harder for cancers to flourish. They’re hacking into the molecular circuitry controlling inflammation, looking for ways to hotwire the system with next-generation drugs.
But what if we could manipulate inflammation to prevent cancer developing in the first place? Recent results suggest that the answer might be anything but next-generation. In fact, it’s been around since Hippocrates.
Better known to most of us by its brand name aspirin, acetylsalicyclic acid has been used for over a century to quell inflammation, and there’s now a body of evidence highlighting its potential in cancer prevention. While there’s still a way to go to work out who should take aspirin, how much, and for how long, it’s becoming clear that blocking inflammation will play a big role in cancer prevention and treatment in the future."
SO WHAT'S MORE EFFECTIVE THAN ASPIRIN?---Anatabine Citrate or better known as Anatabloc.
Article at: http://scienceblog.cancerresearchuk.org/2013/02/01/feeling-the-heat-the-link-between-inflammation-and-cancer/
BBC Article:
Viewpoint: The invisible plague of concussion
By Dr Anand Veeravagu
Senior Neurosurgery Resident, Stanford University
Excerpt:
More than 260,000 of America's veterans from Iraq and Afghanistan have been diagnosed with traumatic brain injury (TBI), the invisible wound of war.
And yet these numbers do not come close to capturing the extent of head injuries suffered by the wider American population.
This year alone, the US Centers for Disease Control (CDC) estimates that over 1.7 million Americans will suffer a traumatic brain injury, whether a mild concussion or something more serious.
During the last decade, emergency room visits for sport- and recreation-related TBIs among children and adolescents increased by almost 60%.
After American football, girls' soccer is the fastest-rising category of teenage TBI.
Article at:
http://www.bbc.co.uk/news/world-us-canada-23980191
Teen users of e-Cigs article in Reuters:
"Twice as many U.S. middle and high school students used electronic cigarettes, which mimic traditional cigarettes and deliver nicotine as a vapor, in 2012 than a year earlier, and these teens could be on the way to a lifelong addiction, according to a government report released on Thursday."
The Centers for Disease Control and Prevention said 10 percent of high school students surveyed reported using e-cigarettes in 2012, up from 4.7 percent in 2011.
Some 2.7 percent of middle school students surveyed had used e-cigarettes in 2012, up from 1.4 percent in 2011.
Last year, nearly 1.8 million middle and high school students nationwide tried e-cigarettes, the report said."
Article at:
http://www.reuters.com/article/2013/09/05/us-usa-health-e-cigarettes-idUSBRE9840X820130905?feedType=RSS&feedName=healthNews
Also, if you buy from Lucky, you will get $15 discount code 30 days after your purchase (Lucky Rewards). so your next purchase will be $80 minus $15 or $65 per bottle. They also provide free shipping for orders over $49. (someone previously mentioned that Lucky is owned by GNC)
You can find Anatabloc at Lucky here:
http://www.luckyvitamin.com/p-405858-anatabloc-anti-inflammatory-support-dietary-supplement-unflavored-300-tablets?utm_source=amazonpa&utm_medium=CPC&utm_term=Anatabloc-Anti-InflammatorySupportDietarySupplementUnflavored-300Tablets&utm_content=125711&utm_campaign=amazonpa&site=www.amazonproductads.com&mr:trackingCode=D3D3F5BF-269D-E211-ACC7-001B2163195C&mr:referralID=NA&
You're correct! Used in Thyroid trials. Found it in parentheses at:
http://clinicaltrials.gov/show/NCT01551498
Looks like only applies to certain GNC branded products, not Anatabloc
BTW I sent an email to Rock Creek pointing out possible error. (Unless of course they have a new 3 mg Anatabloc we don't know about)
From the Journal of The International Society of Sports Nutrition:
Title: "The effects of anatabine on non-invasive indicators of muscle damage: a randomized, double-blind, placebo-controlled, crossover study"
Conclusion:
"ANA supplementation had no effect on the recovery of muscle strength, hanging joint angle, arm swelling, or subjective pain ratings after a bout of maximal eccentric exercise in the forearm flexors. Therefore, ANA may not be beneficial for those seeking to improve recovery from heavy eccentric exercise. Future studies should examine the effects of ANA on the pro-inflammatory cytokine responses to exercise-induced muscle damage and the chronic low-grade inflammation observed in obese and elderly individuals."
Acknowledgement:
This study was funded by a research grant from Rock Creek Pharmaceuticals, Inc. Rock Creek Pharmaceuticals, Inc. had no involvement in the data collection, analysis and interpretation of the data, writing of the manuscript, or in the decision to submit the manuscript for publication.
"The schedule for consuming the lozenges during each 10 day period was as follows: (a) 1 lozenge at breakfast and lunch on days 1 and 2, (b) 1 lozenge at breakfast, lunch, and dinner on days 3 and 4, and (c) 2 lozenges at breakfast and 1 at lunch and dinner on days 5–10. Therefore, during the ANA condition, the participants consumed 6 mg of ANA during days 1 and 2, 9 mg during days 3 and 4, and 12 mg during days 5 through 10."
My take....BIG MISTAKE! Assumption is one lozenge equals three(3) mg Anatabloc. If the lozenges taken are the same ones we retail consumers buy from Rock Creek/GNC, ONE LOZENGES EQUALS ONE MG OF ANATABLOC,NOT THREE. So these athletes took only 2mg on days 1 and 2 (report says 6mg), 3mg on days 3 and 4 (report says 9mg), and 4mg on days 5 thru 10 (report says 12mg). Dosage doesn't even follow Rock Creek's recommendation based on weight.
REVISED CONCLUSION: Research appears to be incorrect.
.
Johnnie Williams Patents and Marijuana. Take a look at the three pages of patents attributed to Johnnie Williams. His process for curing tobacco is also applicable to marijuana. Marijuana may become big time business now with 21 states approving it's legal medical use.
"Methods of reducing the content of and preventing formation of carcinogenic nitrosamines in harvested leafy plants such as tobacco and marijuana, are disclosed. The methods are directed to subjecting the plant to microwave radiation, at appropriate times in the cure cycle......"
http://www.patentmaps.com/inventor/WILLIAMS_Jonnie_R_1.html
Also there is an article related to marijuana usage and possible usage to benefit autoimmune disorder patients.
"Marijuana is the most commonly used illicit drug in the
United States, and use is increasing. The 2010 National
Survey on Drug Use and Health reported that between 2007
and 2010, the prevalence of marijuana use among persons aged
12 years and older increased from 5.8% to 6.9%, meaning there
are an estimated 17.4 million current users of marijuana.
Approximately 4.6 million of these users smoked marijuana
daily or almost daily.1
With the recent legalization of recreational marijuana in 2 states and the legalization of medical
marijuana in 19 states and the District of Columbia, physicians
will increasingly encounter marijuana use among their patient
populations.----With the recent trends in legalization of marijuana in the United States, it is likely that physicians will increasingly encounter patients who use marijuana and should therefore be aware of the effects it can have on common
disease processes, such as diabetes mellitus. We found
that current marijuana use is associated with lower levels
of fasting insulin, lower HOMA-IR, and smaller waist
circumference."
Article at: http://www.amjmed.com/webfiles/images/journals/ajm/AJM11994.pdf
Another article cites Marijuana benefits:
"Tobacco and cannabis smoke contain the same carcinogenic compounds - and depending on which part of the plant is smoked, cannabis smoke can contain more of them - but, whereas nicotine activates these carcinogenic compounds, THC has been shown to inhibit them in mice cells. THC is very likely to have protective effects against the carcinogens present in smoke in humans too, but cannabis smoke remains nonetheless carcinogenic.
While nicotine and THC can act on related cellular pathways, they bind to different receptors to activate these pathways. The cells of lungs and the respiratory passages are lined with nicotine receptors, but do not appear to carry THC receptors. This explains why cannabis smoking has not been associated with lung cancer, a main cause of death from cigarette smoking.
"Cannabis has also been shown to kill cancer cells and to reduce tumour growth, in part by reducing the formation of blood vessels that feed tumours. But "the effects of cannabinoids are complex and sometimes contradicting", warns the author. In addition, as cannabis is frequently smoked with tobacco, the effects of the two drugs may interact in complex ways.
Cannabis is a class C drug in the UK and the USA. It has been linked to an increased risk of psychosis and schizophrenia, in a small group of vulnerable individuals. But there is increasing evidence that the drug has significant medicinal uses and can greatly improve the lives of patients suffering from a wide range of conditions, including multiple sclerosis, AIDS, Alzheimer's disease and insomnia. In spite of this, governments have been reluctant to legalize cannabis for medical use, on the grounds that the risks associated with the drug still outweigh its benefits."
Article at: http://www.medicalnewstoday.com/releases/32229.php
And finally an article from Rosenkamp"
"A new study conducted by researchers at the Roskamp Institute in Florida, and published in the journal Molecular and Cellular Neuroscience,MMMA LEAF AND SYMBOL_full has found that cannabis can slow the effects of Alzheimer’s Disease, and may in fact be able to halt it entirely.
According to Corbin Bachmeier, Ph.D – who’s the lead researcher of the study – Alzheimer’s Disease is “the result of impaired Aß [Amyloid-ß protein] clearance from the brain”. According to this study, cannabis can solve this problem, making it a potential treatment."
Article at: http://thejointblog.com/new-study-cannabis-can-slow-cure-alzheimers-disease/
Interesting articles to say the least. Trying to connect the dots. I wonder what in cannabis makes it behave in a parallel fashion to anatabine? Could it be that anatabine is also a constituent of cannabis? With the popularity of cannabis increasing, only a matter of time for researchers to explore what makes cannabis tick.
FYI re Polio and TB Vaccines:
Re Polio:
"Injections: Several studies have shown that injections (for antibiotics or other vaccines) increase susceptibility to polio. In fact, researchers have known since the early 1900s that paralytic poliomyelitis often started at the site of an injection.(10,11) When diphtheria and pertussis vaccines were introduced in the 1940s, cases of paralytic poliomyelitis skyrocketed [Figure 1].(12) This was documented in Lancet and other medical journals.(13-15) In 1949, the Medical Research Council in Great Britain set up a committee to investigate the matter and ultimately concluded that individuals are at increased risk of paralysis for 30 days following injections; injections alter the distribution of paralysis; and it did not matter whether the injections were subcutaneous or intramuscular.(16,17)
A 1992 study, published in the Journal of Infectious Diseases, validated earlier findings. Children who received DPT (diphtheria, tetanus, and pertussis) injections were significantly more likely than controls to suffer paralytic poliomyelitis within the next 30 days.(18) According to the authors, "this study confirms that injections are an important cause of provocative poliomyelitis."(19)
In 1995, the New England Journal of Medicine published a study showing that children who received a single injection within one month after receiving a polio vaccine were 8 times more likely to contract polio than children who received no injections. The risk jumped 27-fold when children received up to nine injections within one month after receiving the polio vaccine. And with ten or more injections, the likelihood of developing polio was 182 times greater than expected.(20)
Why injections increase the risk of polio is unclear.(21) Nevertheless, these studies and others(22-27) indicate that "injections must be avoided in countries with endemic poliomyelitis."(28) Health authorities believe that all "unnecessary" injections should be avoided as well.(29)"
Article at: http://thinktwice.com/polio.htm
Re TB:
TB vaccines take the form of BCG vaccine(Bacillus Calmette–Guérin) whic has some adverse effects but has a better track record than most vaccines.
"BCG is one of the most widely used vaccines in the world, with an unparalleled safety record[citation needed]. BCG immunization generally causes some pain and scarring at the site of injection. The main adverse effects are keloids—large, raised scars. The insertion of deltoid is most frequently used because the local complication rate is smallest when that site is used. Nonetheless, the buttock is an alternative site of administration because it provides better cosmetic outcomes.
BCG vaccine should be given intradermally. If given subcutaneously, it may induce local infection and spread to the regional lymph nodes, causing either suppurative and nonsuppurative lymphadenitis. Conservative management is usually adequate for nonsuppurative lymphadenitis. If suppuration occurs, it may need needle aspiration. For nonresolving suppuration, surgical excision is required, but not incision. Uncommonly, breast and gluteal abscesses can occur due to haematogenous and lymphangiomatous spread. Regional bone infection (BCG osteomyelitis or osteitis) and disseminated BCG infection are rare complications of BCG vaccination, but potentially life threatening. Systemic antituberculous therapy may be helpful in severe complications.[40]"
Article at: http://en.wikipedia.org/wiki/BCG_vaccine